Recombinant Human CBX5 Protein，His

CBX5, also known as Chromobox protein homolog 5, is a member of the Polycomb Group (PcG) proteins, which play a crucial role in the regulation of gene expression and cellular identity through epigenetic mechanisms. CBX5 is specifically recognized for its function in maintaining transcriptional repression through histone methylation, particularly binding to trimethylated histone H3 at lysine 9 (H3K9me3). This protein is integral to the formation of heterochromatin, which helps stabilize gene silencing during development and cell differentiation. Research into CBX5 has garnered significant interest due to its involvement in various biological processes, including cell proliferation, differentiation, and the regulation of stem cell pluripotency. Abnormal expression or dysregulation of CBX5 has been associated with several diseases, including cancer, where it may contribute to tumor progression and metastasis by modulating key target genes responsible for cell cycle regulation and apoptosis. Consequently, the study of recombinant CBX5 protein has become essential in understanding its functional mechanisms and potential roles in therapeutic interventions. Researchers are exploring its binding affinities, structural properties, and interactions with other chromatin-associated proteins to elucidate its contribution to epigenetic regulation and to develop targeted strategies for cancer treatment and regenerative medicine. Overall, the investigation of CBX5 and its recombinant forms holds promise for advancing our understanding of epigenetic control mechanisms and their implications in health and disease.